IGM Biosciences, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

IGM Biosciences, Inc. Share Price Chart

$0.00$0.00

IGM Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025
Revenue	N/A	N/A	N/A	N/A
Net Profit	-$49.82M	-$47.90M	-$61.43M	-$52.89M
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	3.84%	-28.24%	13.90%

IGM Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023
Revenue	N/A	N/A
Net Profit	-$221.10M	-$246.42M
Net Profit Margin	N/A	N/A
Income Change	N/A	-11.45%

About IGM Biosciences, Inc.

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

IGM Biosciences, Inc. Historical Returns

Month	Open	Close	Change %

IGMS Share Price FAQs

What is IGM Biosciences, Inc. share price today?

IGM Biosciences, Inc. share price today is $0.00 as on August 9, 2026 at 1:11 pm IST.

What is the 52 week high and 52 week low of IGM Biosciences, Inc. stock?

52 week high/low data for IGM Biosciences, Inc. is currently unavailable.

What is IGMS's net income for the last quarter?

IGMS's net income for the last quarter is -0.05B USD.

Can I buy IGMS shares in India?

Yes. You can buy IGMS in India by opening an international trading account.